rs141462728
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting
The NM_002906.4(RDX):c.1037A>C(p.Glu346Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,611,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002906.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000530 AC: 13AN: 245390Hom.: 0 AF XY: 0.0000602 AC XY: 8AN XY: 132960
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1459372Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 725916
GnomAD4 genome AF: 0.000177 AC: 27AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74488
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
The RDX p.Glu346Ala variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs141462728) and ClinVar (classified as a VUS by Laboratory for Molecular Medicine). The variant was also identified in control databases in 22 of 276790 chromosomes at a frequency of 0.000079 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 21 of 24808 chromosomes (freq: 0.000847) and Latino in 1 of 35112 chromosomes (freq: 0.000028), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish), Other or South Asian populations. The p.Glu346 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
not specified Uncertain:1
The p.Glu346Ala variant in RDX has not been previously reported in individuals w ith hearing loss. It has been identified in 7/9366 African chromosomes by the Ex ome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs141492 728). Although this variant has been seen in the general population, its frequen cy is not high enough to rule out a pathogenic role. Computational prediction to ols and conservation analyses do not provide strong support for or against an im pact to the protein. In summary, the clinical significance of the p.Glu346Ala v ariant is uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at